- Previous Close
0.0001 - Open
0.0001 - Bid --
- Ask --
- Day's Range
0.0001 - 0.0001 - 52 Week Range
0.0000 - 0.0100 - Volume
93,100 - Avg. Volume
8,199 - Market Cap (intraday)
154,538 - Beta (5Y Monthly) 5.95
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
ObsEva SA, a biopharmaceutical company, focuses on the development of novel therapies to improve women's reproductive health. It develops Nolasiban, an oral oxytocin receptor agonist for improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland.
www.obseva.comRecent News: OBSEF
View MorePerformance Overview: OBSEF
Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OBSEF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OBSEF
View MoreValuation Measures
Market Cap
1.17k
Enterprise Value
1.17k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.00
Price/Book (mrq)
0.00
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
40.34%
Return on Assets (ttm)
10.05%
Return on Equity (ttm)
1,576.52%
Revenue (ttm)
19.64M
Net Income Avi to Common (ttm)
7.92M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
3.34M
Total Debt/Equity (mrq)
24.32%
Levered Free Cash Flow (ttm)
20.15M